1800-272-662
Shopping Cart 0
countryflagAU
Login

BPH Global Ltd

Healthcare AU BP8

0.002AUD
-(-%)

Last update at 2026-03-11T02:45:00Z

Day Range

0.0020.002
LowHigh

52 Week Range

0.0010.005
LowHigh

Fundamentals

  • Previous Close 0.002
  • Market Cap4.71M
  • Volume58431
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.00303M
  • Revenue TTM1.73M
  • Revenue Per Share TTM0.002
  • Gross Profit TTM -0.03579M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -1.48718M -1.77758M -3.53673M -2.79261M -2.85624M
Minority interest - 0.18M -0.21607M -0.74506M 0.93M
Net income -1.48655M -2.27158M -4.31797M -2.85525M -3.38141M
Selling general administrative - 0.98M 1.76M 3.13M 2.94M
Selling and marketing expenses - 0.26M - 0.18M 0.14M
Gross profit -0.67802M 0.02M 0.00034M 2.39M 1.54M
Reconciled depreciation - - 0.02M 0.24M 0.42M
Ebit -1.45344M - -2.53503M -2.72997M -2.50282M
Ebitda -1.45328M -1.75717M -2.35050M -2.49480M -2.08217M
Depreciation and amortization 0.00017M - - 0.24M 0.42M
Non operating income net other - - - - -
Operating income -1.45585M -1.75488M -2.36999M -2.72997M -2.50282M
Other operating expenses 1.81M 1.86M 0.00004M 17.14M 11.25M
Interest expense 0.03M 0.02M - 0.06M 0.02M
Tax provision - 0.00000M 0.00000M 0.00000M 0.00000M
Interest income - - - - -
Net interest income - -0.02041M - -0.06264M -0.02412M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - 0.06M 0.53M
Total revenue 0.35M 0.11M 0.00034M 14.34M 8.50M
Total operating expenses 0.78M 1.77M - 5.19M 4.30M
Cost of revenue 1.03M 0.09M - 11.95M 6.95M
Total other income expense net -0.03133M -0.02270M -1.16674M -0.06264M -0.35343M
Discontinued operations - - -0.56517M 1.62M 1.62M
Net income from continuing ops - -1.77758M -3.53673M -2.79261M -2.85624M
Net income applicable to common shares - - -4.82797M -3.53767M -2.81357M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 0.54M 0.28M 1.89M 7.62M 9.23M
Intangible assets - 0.00000M - 0.00000M 0.00000M
Earning assets - - - - -
Other current assets 0.04M - 0.00083M 0.25M 0.52M
Total liab 2.01M 1.70M 1.19M 2.90M 2.75M
Total stockholder equity -1.45034M -1.40554M 0.53M 3.04M 5.55M
Deferred long term liab - - - - -
Other current liab 1.67M - 0.55M 1.64M 1.78M
Common stock 80.20M - 78.19M 76.88M 76.57M
Capital stock - 78.88M 78.28M 76.88M 76.93M
Retained earnings -83.44629M -82.20401M -81.30815M -77.96694M -74.74900M
Other liab - - - -0.00000M -
Good will - - - - -
Other assets - - - - -
Cash 0.15M 0.13M 0.51M 0.62M 5.26M
Cash and equivalents - - - 0.62M 5.26M
Total current liabilities 2.01M 1.70M 1.28M 2.81M 2.64M
Current deferred revenue - - - - -
Net debt -0.15274M 0.12M - 0.63M -4.28479M
Short term debt - - - 1.16M 0.86M
Short long term debt - 0.25M - 1.09M 0.79M
Short long term debt total - - - 1.25M 0.97M
Other stockholder equity - - 3.14M -0.15190M 0.28M
Property plant equipment - - 0.63M 1.71M 0.98M
Total current assets 0.54M 0.28M 0.63M 5.94M 8.26M
Long term investments - - - 0.00000M 0.00000M
Net tangible assets - - 0.02M 3.20M 5.55M
Short term investments - 0.00121M 0.63M 0.06M -
Net receivables 0.21M - 0.02M 3.35M 1.77M
Long term debt - - - 0.04M -
Inventory 0.14M 0.05M - 1.32M 0.71M
Accounts payable 0.33M 0.00062M 0.00062M 0.00884M 0.00838M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1.80M - - 4.29M 3.45M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - -0.02608M -
Deferred long term asset charges - - - - -
Non current assets total 0.00221M 0.00000M 0.63M 1.69M 0.98M
Capital lease obligations - - - 0.12M 0.18M
Long term debt total - - - 0.09M 0.11M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - 0.19M 0.00629M -0.91421M -0.41804M
Change to liabilities - - 0.20M -0.24734M 0.32M
Total cashflows from investing activities -0.00237M 0.19M -0.08204M -0.91421M -0.43447M
Net borrowings - 0.38M -0.10669M 0.28M -0.06242M
Total cash from financing activities 0.96M 0.70M 1.38M 0.28M 6.25M
Change to operating activities - - 0.68M -0.18107M -0.51715M
Net income -1.48655M -2.27158M -4.82797M -2.85525M -3.46260M
Change in cash 0.02M -0.37660M -0.11474M -4.63031M 4.39M
Begin period cash flow 0.13M 0.51M 0.62M 5.26M 0.87M
End period cash flow 0.15M 0.13M 0.51M 0.62M 5.26M
Total cash from operating activities -0.92981M - -1.33963M -2.62009M -1.34503M
Issuance of capital stock - 0.32M 1.49M - 6.29M
Depreciation 0.00017M - 0.12M 0.24M 0.42M
Other cashflows from investing activities - - - 0.00000M 0.01M
Dividends paid - - - - -
Change to inventory -0.08952M - -0.12611M -0.60745M 0.32M
Change to account receivables -0.10964M - -0.48731M -1.53638M -1.22161M
Sale purchase of stock - - - 0.00000M 6.29M
Other cashflows from financing activities - - - 1.07M 0.15M
Change to netincome - - 3.10M -0.71749M 1.65M
Capital expenditures 0.00237M 0.00000M 0.15M 0.91M 0.43M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.42M - - 0.02M 0.14M
Stock based compensation - - - - -
Other non cash items 0.14M - - 2.62M 2.71M
Free cash flow -0.93218M -1.25888M -1.48675M -3.53430M -1.77605M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BP8
BPH Global Ltd		 - -% 0.002 - - 2.72 91.17 2.79 -3.899
AFP
Aft Pharmaceuticals Ltd		 - -% 3.00 23.85 19.88 1.40 3.89 1.68 13.38
VLS
Vita Life Sciences Ltd		 0.01 0.40% 2.50 14.06 42.73 1.51 2.56 1.19 7.04
SNT
Syntara Ltd		 -0.001 3.23% 0.03 - 22.83 6.97 4.78 6.13 -2.1607
MVP
Medical Developments International Ltd		 0.005 1.25% 0.41 - 166.67 1.19 0.88 0.82 12.54

Reports Covered

Stock Research & News

View All

Profile

BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. BPH Global Ltd was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. The company was incorporated in 1984 and is headquartered in Melbourne, Australia.

BPH Global Ltd

365 Little Collins Street, Melbourne, VIC, Australia, 3000

Key Executives

Name Title Year Born
Mr. Huan Qing Gu CEO, MD & Director NA
Mr. Chow-Yee Koh CFO & Director 1976
Ms. Elizabeth Spooner Joint Company Sec. NA
Ms. Belinda Cleminson Joint Company Sec. NA
Mr. Francesco Cannavo Part-Time Executive Director NA
Mr. Matthew Leonard MD & Executive Director NA
Mr. Chow-Yee Koh Chief Financial Officer 1976
Mr. Francesco Cannavo Part-Time Executive Director NA
Ms. Belinda Cleminson Joint Company Secretary NA
Ms. Shelby Coleman Joint Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.